Team:Queens-Canada/safety
From 2010.igem.org
(→Risk Assessment) |
(→Risk Assessment) |
||
Line 6: | Line 6: | ||
Unlike some other nematodes, ''Caenorhabditis elegans'' is fully free-living and functions primarily as a digester of detritus, posing no threat except to those organisms (mostly bacteria) which it eats. Accordingly, concerns about researcher, public, and environmental safety are minimal. ''C. elegans'' can be safely cultured in a BSL-1 laboratory{{:Team:Queens-Canada/footnote-anchor|1}}. Since the worms are non-pathogenic organisms, and Biosafety level 1 practices are simple and safe, working with ''C. elegans'' carries a very low level of risk. | Unlike some other nematodes, ''Caenorhabditis elegans'' is fully free-living and functions primarily as a digester of detritus, posing no threat except to those organisms (mostly bacteria) which it eats. Accordingly, concerns about researcher, public, and environmental safety are minimal. ''C. elegans'' can be safely cultured in a BSL-1 laboratory{{:Team:Queens-Canada/footnote-anchor|1}}. Since the worms are non-pathogenic organisms, and Biosafety level 1 practices are simple and safe, working with ''C. elegans'' carries a very low level of risk. | ||
- | The engineered ''C. elegans'' do not effect their environments, as our work focuses on proteins with intracellular effects that have no significant catalytic role. Thus, a malfunction in our BioBrick parts would pose minimal threat to humans, laboratory equipment, or other organisms. Further, our alterations do not grant the worms any advantages over indigenous genotypes. | + | The engineered ''C. elegans'' do not effect their environments, as our work focuses on proteins with intracellular effects that have no significant catalytic role. Thus, a malfunction in our BioBrick parts would pose minimal threat to humans, laboratory equipment, or other organisms. Further, our alterations do not grant the worms any advantages over indigenous genotypes, and ''C. elegans'' does not conduct horizontal gene transfer in the way that some prokaryotes and plants do, making the spread of these alleles unlikely, should engineered worms be released into the environment. |
=Footnotes and Citations= | =Footnotes and Citations= | ||
{{:Team:Queens-Canada/footnote|1|[http://www.ccac.ca/en/CCAC_Programs/ETCC/Module04/15.html Biosafety Guidelines and Levels of Containment]. Canadian Council on Animal Care. Accessed on 2010-06-22.}} | {{:Team:Queens-Canada/footnote|1|[http://www.ccac.ca/en/CCAC_Programs/ETCC/Module04/15.html Biosafety Guidelines and Levels of Containment]. Canadian Council on Animal Care. Accessed on 2010-06-22.}} | ||
{{:Team:Queens-Canada/foot}} | {{:Team:Queens-Canada/foot}} |
Revision as of 15:39, 24 June 2010
Please use this page to answer the safety questions posed on the safety page.
Risk Assessment
Unlike some other nematodes, Caenorhabditis elegans is fully free-living and functions primarily as a digester of detritus, posing no threat except to those organisms (mostly bacteria) which it eats. Accordingly, concerns about researcher, public, and environmental safety are minimal. C. elegans can be safely cultured in a BSL-1 laboratory1. Since the worms are non-pathogenic organisms, and Biosafety level 1 practices are simple and safe, working with C. elegans carries a very low level of risk.
The engineered C. elegans do not effect their environments, as our work focuses on proteins with intracellular effects that have no significant catalytic role. Thus, a malfunction in our BioBrick parts would pose minimal threat to humans, laboratory equipment, or other organisms. Further, our alterations do not grant the worms any advantages over indigenous genotypes, and C. elegans does not conduct horizontal gene transfer in the way that some prokaryotes and plants do, making the spread of these alleles unlikely, should engineered worms be released into the environment.
Footnotes and Citations
1: [http://www.ccac.ca/en/CCAC_Programs/ETCC/Module04/15.html Biosafety Guidelines and Levels of Containment]. Canadian Council on Animal Care. Accessed on 2010-06-22.